Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma

[1]  J. Kaouk,et al.  Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors , 2017, The Journal of urology.

[2]  C. Kwak,et al.  Clinical Significance of Subclassification of Papillary Renal Cell Carcinoma: Comparison of Clinicopathologic Parameters and Oncologic Outcomes Between Papillary Histologic Subtypes 1 and 2 Using the Korean Renal Cell Carcinoma Database , 2017, Clinical genitourinary cancer.

[3]  K. Bensalah,et al.  A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma. , 2017, European urology.

[4]  P. Lo,et al.  Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. , 2017, AJR. American journal of roentgenology.

[5]  Katsuyoshi Ito,et al.  Differentiation of subtypes of renal cell carcinoma: dynamic contrast-enhanced magnetic resonance imaging versus diffusion-weighted magnetic resonance imaging. , 2017, Clinical imaging.

[6]  B. Iványi,et al.  Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients , 2017, Pathology & Oncology Research.

[7]  P. Russo,et al.  Reply to Williamson S.R. What is the malignant potential of clear cell papillary renal cell carcinoma? Urol Oncol 2016; 34: 420. , 2016, Urologic oncology.

[8]  M. Gallucci,et al.  Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  P. Russo,et al.  Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. , 2016, Urologic oncology.

[10]  Choung-Soo Kim,et al.  Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy , 2016, Journal of Cancer Research and Clinical Oncology.

[11]  S. Girgis,et al.  Multimodality Imaging Characteristics of the Common Renal Cell Carcinoma Subtypes: An Analysis of 544 Pathologically Proven Tumors , 2016, Journal of clinical imaging science.

[12]  K. Bensalah,et al.  The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery , 2016, World Journal of Urology.

[13]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[14]  T. Kawasaki,et al.  The RENAL Nephrometry Score and the PADUA Classification for the Prediction of Perioperative Outcomes in Patients Receiving Nephron-Sparing Surgery: Feasible Tools to Predict Intraoperative Conversion to Nephrectomy , 2013, Urologia Internationalis.

[15]  A. Goh,et al.  Partial nephrectomy—contemporary indications, techniques and outcomes , 2013, Nature Reviews Urology.

[16]  M. Carini,et al.  Prognostic role of tumour multifocality in renal cell carcinoma , 2012, BJU international.

[17]  R. Uzzo,et al.  Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. , 2012, Urology.

[18]  N’Dowa Systematic review of oncological outcomes following surgical management of localised renal cancer , 2012 .

[19]  S. Taneja Re: Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. , 2012, The Journal of urology.

[20]  D. Albala,et al.  Predicting occult multifocality of renal cell carcinoma. , 2010, European urology.

[21]  J. Cheville,et al.  Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. , 2010, The Journal of urology.

[22]  Robert G Uzzo,et al.  The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. , 2009, The Journal of urology.

[23]  R. Vikram,et al.  Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[24]  J. Cheville,et al.  Outcomes following partial nephrectomy by tumor size. , 2008, The Journal of urology.

[25]  Stephen A Boorjian,et al.  Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. , 2008, The Journal of urology.

[26]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[27]  Y. Chrétien,et al.  Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. , 2003, The Journal of urology.